Indeed, single-agent TNG908 was able to drive tumor regressionsin the LU99 MTAP-deleted xenograft model, which highlightsthe potential for TNG908 to drive meaningful clinical responses in MTAP-deleted tumors while maintaining a large therapeuticindex. Here, MTAP is linked to neoplasm.